Clinical & Experimental Immunology

Special Anniversary Review: Twenty-five years of human immunodeficiency virus research: successes and challenges
pp. 201-210(10)
Author: Weiss, R. A.

Special Article: Chronic granulomatous disease in the United Kingdom and Ireland: a comprehensive national patient-based registry
pp. 211-218(8)
Authors: Jones, L. B. K. R.; McGrogan, P.; Flood, T. J.; Gennery, A. R.; Morton, L.; Thrasher, A.; Goldblatt, D.; Parker, L.; Cant, A. J.

Innate lymphocyte and dendritic cell cross-talk: a key factor in the regulation of the immune response
pp. 219-226(8)
Authors: Reschner, A.; Hubert, P.; Delvenne, P.; Boniver, J.; Jacobs, N.

Secretory immunoglobulin A (IgA) responses in IgA nephropathy patients after mucosal immunization, as part of a polymeric IgA response
pp. 227-232(6)
Authors: Eijgenraam, J. W.; Oortwijn, B. D.; Kamerling, S. W. A.; de Fijter, J. W.; van den Wall Bake, A. W. L.; Daha, M. R.; van Kooten, C.

Monitoring non-immediate allergic reactions to iodine contrast media
pp. 233-238(6)
Authors: Torres, M. J.; Mayorga, C.; Cornejo-Garcia, J. A.; Lopez, S.; Chaves, P.; Rondon, C.; Fernandez, T.; Blanca, M.

The value of serum neopterin, interferon-gamma levels and interleukin-12B polymorphisms in predicting acute renal allograft rejection
pp. 239-244(6)
Authors: Chin, G. K.; Adams, C. L.; Carey, B. S.; Shaw, S.; Tse, W.-Y.; Kaminski, E. R.

Involvement of innate immunity in the pathogenesis of intestinal Behçet's disease
pp. 245-251(7)
Authors: Nara, K.; Kurokawa, M. S.; Chiba, S.; Yoshikawa, H.; Tsukikawa, S.; Matsuda, T.; Suzuki, N.

Restoration of anti-tetanus toxoid responses in patients initiating highly active antiretroviral therapy with or without a boost immunization: an INITIO substudy
pp. 252-257(6)
Authors: Burton, C. T.; Goodall, R. L.; Samri, A.; Autran, B.; Kelleher, A. D.; Poli, G.; Pantaleo, G.; Gotch, F. M.; Imami, N.

Mannan-binding lectin MBL2 gene polymorphism in chronic hepatitis C: association with the severity of liver fibrosis and response to interferon therapy
pp. 258-264(7)
Authors: Alves Pedroso, M. L.; Boldt, A. B. W.; Pereira-Ferrari, L.; Steffensen, R.; Strauss, E.; Jensenius, J. C.; Ioshii, S. O.; Messias-Reason, I.

A novel, helminth-derived immunostimulant enhances human recall responses to hepatitis C virus and tetanus toxoid and is dependent on CD56⁺ cells for its action
pp. 265-273(9)
Authors: MacDonald, A. J.; Libri, N. A.; Lustigman, S.; Barker, S. J.; Whelan, M. A.; Semper, A. E.; Rosenberg, W. M.

Rapid subcutaneous immunoglobulin administration every second week results in high and stable serum immunoglobulin G levels in patients with primary antibody deficiencies
pp. 274-279(6)
Authors: Gustafson, R.; Gardulf, A.; Hansen, S.; Leibl, H.; Engl, W.; Lindén, M.; Müller, A.; Hammarström, L.

Atorvastatin does not alter serum levels of sCD95 and sCD95L in multiple sclerosis
pp. 280-284(5)
Authors: Sellner, J.; Greeve, I.; Findling, O.; Grandgirard, D.; Leib, S. L.; Mattle, H. P.

Regulation of galectin-3 function in mucosal fibroblasts: potential role in mucosal inflammation
pp. 285-297(13)
Authors: Lippert, E.; Gunckel, M.; Brenmoehl, J.; Bataille, F.; Falk, W.; Scholmerich, J.; Obermeier, F.; Rogler, G.

Intrahepatic endothelial and Kupffer cells involved in immunosuppressive cytokines and natural killer (NK)/NK T cell disorders in viral acute hepatitis
pp. 298-310(13)
Authors: Jacques, A.; Bleau, C.; Martin, J.-P.; Lamontagne, L.

High mobility group box 1 and adenosine are both released by endothelial cells during hypothermic preservation
pp. 311-319(9)
Authors: Song, H.; Feng, Y.; Hoeger, S.; Beck, G.; Hanusch, C.; Goettmann, U.; Leuvenink, H. G. D.; Ploeg, R. J.; Hillebrands, J.; Yard, B. A.

Lidocaine down-regulates nuclear factor-κB signalling and inhibits cytokine production and T cell proliferation
pp. 320-327(8)
Authors: Lahat, A.; Horin, S. B.; Lang, A.; Fudim, E.; Picard, O.; Chowers, Y.

Up-regulated macrophage migration inhibitory factor protects apoptosis of dermal fibroblasts in patients with systemic sclerosis
pp. 328-335(8)
Authors: Kim, J.-Y.; Kwok, S.-K.; Hur, K.-H.; Kim, H.-J.; Kim, N. S.; Yoo, S.-A.; Kim, W.-U.; Cho, C.-S.

Inhibition of casein kinase 2 enhances the death ligand- and natural kiler cell-induced hepatocellular carcinoma cell death
pp. 336-344(9)
Authors: Kim, H.-R.; Kim, K.; Lee, K.-H.; Kim, S. J.; Kim, J.

The tumour suppressor gene p53 modulates the severity of antigen-induced arthritis and the systemic immune response
pp. 345-353(9)
Authors: Leech, M.; Xue, J. R.; Dacumos, A.; Hall, P.; Santos, L.; Yang, Y.; Li, M.; Kitching, A. R.; Morand, E. F.

CDIP-2, a synthetic peptide derived from chemokine (C-C motif) ligand 13 (CCL13), ameliorates allergic airway inflammation
pp. 354-363(10)
Authors: Mendez-Enriquez, E.; Melendez, Y.; Martinez, F.; Baay, G.; Huerta-Yepez, S.; Gonzalez-Bonilla, C.; Fortoul, T. I.; Soldevila, G.; García-Zepeda, E. A.

Two-dimensional gel electrophoresis analysis in simultaneous influenza pneumonia and bacterial infection in mice
pp. 364-371(8)
Authors: Kosai, K.; Seki, M.; Yanagihara, K.; Nakamura, S.; Kurihara, S.; Imamura, Y.; Izumikawa, K.; Kakeya, H.; Yamamoto, Y.; Tashiro, T.; Kohno, S.

Reduced arthritis in MIF deficient mice is associated with reduced T cell activation: down-regulation of ERK MAP kinase phosphorylation
pp. 372-380(9)
Authors: Santos, L. L.; Dacumos, A.; Yamana, J.; Sharma, L.; Morand, E. F.

Depletion of CD4⁺ CD25⁺ regulatory T cells inhibits local tumour growth in a mouse model of B cell lymphoma
pp. 381-387(7)
Authors: Heier, I.; Hofgaard, P. O.; Brandtzæg, P.; Jahnsen, F. L.; Karlsson, M.